ActiGraft ProĀ® system is described by theNational Coverage Determination (NCD 270.3)Ā as a blood-derived product and is eligible for reimbursement with HCPCS G0465.
ActiGraft Pro system is billed with HCPCS G0465
Effective July 1, 2023, Centers for Medicare & Medicaid Services has added additional language to the code descriptors for HCPCS code G0460 and HCPCS G0465.
ā¢HCPCS G0460
Autologous platelet rich plasma or other blood-derived product for non-diabetic chronic wounds/ulcers, including as applicable phlebotomy, centrifugation or mixing, and all other preparatory procedures, administration and dressings, per treatment
ā¢HCPCS G0465
Autologous platelet rich plasma (PRP) or other blood-derived product for diabetic chronic wounds/ulcers, using an FDA-cleared device for this indication, (includes as applicable administration, dressings, phlebotomy, centrifugation or mixing, and all other preparatory procedures, per treatment)